esketamine
Articles tagged with “esketamine”
Study: CBT After Ketamine Cuts Depression Relapse Risk
The CBT-ENDURE trial shows adding 16 weeks of CBT to esketamine outperforms ketamine alone for depression and suicidal ideation.
NMDA Antagonist Side Effects: What Tablet Users Need to Know
New clinical data on NMDA antagonist side effects and dropout rates has real implications for oral ketamine tablet users. Here's what the research means for you.
Why Patients Quit Ketamine Early—And How Tablets Factor In
New clinical data on NMDA antagonist dropout rates reveals how side effect management and route of administration affect treatment-resistant depression outcomes.
NMDA Antagonist Side Effects: What Tablet Users Should Know
New research in Psychiatric Times breaks down side effect profiles and discontinuation rates for NMDA antagonists — here's what it means for oral ketamine tablet users.
Ketamine Side Effects & Dropout Rates: What Data Says
New analysis in Psychiatric Times urges data-driven ketamine dosing. Here's what the side-effect and dropout data means for oral tablet users.
Glutamate Pathway Treatments Reshape TRD Care in 2026
New research highlights how glutamate-targeting drugs like esketamine and ketamine are reshaping treatment-resistant depression care. Here's what it means for oral ketamine users.
Glutamate Pathway Treatments Reshaping TRD Care
New research highlights glutamate-based therapies like esketamine and ketamine tablets for treatment-resistant depression. Here's what it means for oral ketamine users.
How Doctors Choose TRD Treatments in 2026
Clinicians weigh patient preference, speed of action, and access when choosing TRD treatments. Here's what that means for oral ketamine tablet patients.
Esketamine for Treatment-Resistant Depression in 2026
Clinicians are increasingly turning to esketamine for TRD and suicidal ideation. Here's what it means for oral ketamine tablet users in 2026.
Glutamate Pathway Drugs Are Reshaping TRD Care
New research highlights how glutamate-targeting drugs like esketamine and oral ketamine are changing treatment-resistant depression care in 2026.
Ketamine FDA Status: Approval History, Off-Label Use, and Tablet Formulations
Understand ketamine's FDA approval status, why tablets are prescribed off-label, and what that means for your treatment safety.
Contact Ketamine Tablet
Send corrections, provider questions, or advertising inquiries.